ReachMD

Episodes 1-15 of 15

• • 

    

    Michael Ayala

    Peer

  • 

    

    Russell Rosenberg, Ph.D., D.ABSM

    Peer

  • 

    

    Michael J. Strunc, MD

    Peer

  3

  

  RestartResume

  Understanding a Treatment Option for Excessive Daytime Sleepiness in Obstructive Sleep Apnea

  Understanding a Treatment Option for Excessive Daytime Sleepiness in Obstructive Sleep Apnea

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Suma Satti, MD

    Peer

  7

  

  RestartResume

  Exploring First-Line Treatment in Extensive-Stage Small Cell Lung Cancer

  Exploring First-Line Treatment in Extensive-Stage Small Cell Lung Cancer

• • 

    

    Paul Doghramji, MD

    Peer

  • 

    

    Raymond Benza, MD

    Peer

  1

  

  RestartResume

  Exploring Risk Assessment Strategies and a Treatment Option for Pulmonary Arterial Hypertension

  Exploring Risk Assessment Strategies and a Treatment Option for Pulmonary Arterial Hypertension

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Antonio Anzueto, MD

    Peer

  13

  

  RestartResume

  Why the Prevention of COPD Exacerbations Demands a Proactive Therapeutic Approach

  Why the Prevention of COPD Exacerbations Demands a Proactive Therapeutic Approach
• 3

  

  RestartResume

  Potential Mechanisms of Chronic Cough

  Potential Mechanisms of Chronic Cough

• • 

    

    Vincent Hsu, MD

    Peer

  2

  

  RestartResume

  How to Talk About Pneumococcal Disease With Your Adult Patients at Increased Risk

  How to Talk About Pneumococcal Disease With Your Adult Patients at Increased Risk

• • 

    

    Vincent Hsu, MD

    Peer

  1

  

  RestartResume

  CDC Recommendations for Pneumococcal Disease in Adults Under Age 65 With Certain Chronic Conditions

  CDC Recommendations for Pneumococcal Disease in Adults Under Age 65 With Certain Chronic Conditions

• • 

    

    Javeed Siddiqui, MD, MPH

    Peer

  1

  

  RestartResume

  Understanding 2019 CDC Recommendations for Pneumococcal Disease in Adults Ages 65+

  Understanding 2019 CDC Recommendations for Pneumococcal Disease in Adults Ages 65+

• • 

    

    Paul Doghramji, MD

    Peer

  2

  

  RestartResume

  Challenges in Identifying, Assessing, & Monitoring Excessive Daytime Sleepiness in Obstructive Sleep Apnea

  Challenges in Identifying, Assessing, & Monitoring Excessive Daytime Sleepiness in Obstructive Sleep Apnea

• • 

    

    Richard K. Bogan, MD

    Peer

  1

  

  RestartResume

  Pathophysiology of Obstructive Sleep Apnea & Its Role in Excessive Daytime Sleepiness

  Pathophysiology of Obstructive Sleep Apnea & Its Role in Excessive Daytime Sleepiness

• • 

    

    Richard K. Bogan, MD

    Peer

  4

  

  RestartResume

  Prevalence of Excessive Daytime Sleepiness in Obstructive Sleep Apnea

  Prevalence of Excessive Daytime Sleepiness in Obstructive Sleep Apnea

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Victor F Tapson, MD

    Peer

  2

  

  RestartResume

  When Were Oral PPAs Considered for PAH Patients in Common Clinical Scenarios?

  When Were Oral PPAs Considered for PAH Patients in Common Clinical Scenarios?

• • 

    

    MeiLan K. Han, MD, MS

    Peer

  4

  

  RestartResume

  Unleash the Truth About COPD

  Unleash the Truth About COPD

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Richard Channick, MD

    Peer

  2

  

  RestartResume

  Exploring Earlier Initiation of Treatment for Pulmonary Arterial Hypertension

  Exploring Earlier Initiation of Treatment for Pulmonary Arterial Hypertension
• 4

  

  RestartResume

  Results of an Expert Delphi Consensus Survey on Clinical Scenarios Considered When Initiating Oral Prostacyclin Pathway Agents for Pulmonary Arterial Hypertension

  Results of an Expert Delphi Consensus Survey on Clinical Scenarios Considered When Initiating Oral Prostacyclin Pathway Agents for Pulmonary Arterial Hypertension